Two reports show decreased ceramide in CBE-treated murine cerebellar granule neurons [55], and in GBA1 knock-out SK-N-SH neuroblastoma cells [56], but overall, there is no clear trend of regional or neuronal phenotype-specific ceramide change in the GD brain. The gene discussed is GBA1; the disease is neuroblastoma.